Restructuring of the database equity structure of the former Ant Group; Overseas motorcycle brand received Series A financing|Investment Express

TIPS

1. Download the IT Orange APP to track investment and financing events in the primary market at home and abroad in real time. 2. Please indicate that the source is from IT orange (itjuzi521), and the infringement must be investigated. 3. Establish a long-term release cooperation of "Investment Express", please send an email to [email protected].

July 1, 2024

IT 桔子(itjuzi521)

Includes 24 investment/acquisition/IPO queue events

OceanBase's shareholding structure was adjusted and the shares were jointly held by multiple parties.

OceanBase is a financial-grade distributed relational database independently developed by Ant Financial and Alibaba, founded in 2010. ApsaraDB for OceanBase has the characteristics of strong data consistency, high availability, high performance, online scalability, high compatibility with SQL standards and mainstream relational databases, and low cost.

Recently, the change of industrial and commercial information shows that Beijing Aoxing Bess Technology Co., Ltd., the main company of the database OceanBase, a former subsidiary of Ant Group, has completed the adjustment of its equity structure and accelerated its independent market orientation.

URTOPIA HAS RAISED OVER $10 MILLION IN SERIES A FINANCING. This round of financing was co-led by Guangyuan Harmony, EclickWorld and Tongxiang Jintong Fund, followed by Kongho Fund, Brizan Ventures and Professor Gao Bingqiang, and the old shareholder DCM Capital continued to increase.

URTOPIA is an overseas e-bike brand, creating a product line including e-bikes and various peripheral products, and directly reaching European and American users through the "DTC+BTB" model. In order to meet the individual needs of cycling enthusiasts, "URTOPIA" products are lightweight, intelligent and technological aesthetics.

The funds from this round of financing will be used for the expansion of sales network, technology research and development, and the construction of its own factory.

Domestic investment events

1. Soundtone Technology received a cornerstone round of investment

Shengtong Technology is a professional service provider of call center system solutions, the company focuses on product development and integration in the field of computer communications, is a professional service provider of cloud call center (hosted call center) and call center system solutions, and is also the only supplier and partner of cloud communication services in Xinhuanet Internet Town, the products cover voice, fax, email, SMS and other multimedia communication products, and the customers served cover communication operators, automobile services, Internet, finance and insurance, real estate, tourism, education and training, IT, electronics and other fields. Shengtong Technology has launched a roadshow to prepare for listing on the Hong Kong Stock Exchange on July 10, 2024. Shengtong Technology issued 4,365,660 shares at an issue price of HK$152.1, raising a total of HK$664 million, with a net proceeds of HK$572 million after deducting non-issuance expenses. Two cornerstone investors, Wuhan Guangtong Win-Win Enterprise Management Partnership (Limited Partnership) and Jiangsu Jiangkong Investment Co., Ltd., were introduced, with a total subscription of 250 million yuan, of which Guangtong Win-Win subscribed 200 million yuan and Jiangkong subscribed 50 million yuan.

2. One Intelligence completed the angel round of financing

No.1 Intelligence is a R&D and manufacturer of intelligent warehousing robots, focusing on dense storage segments, providing close storage ecosystem solutions to global customers, and helping customers efficiently complete the implementation and delivery of dense storage projects from all aspects such as scheme design, project management, equipment commissioning and system scheduling. Recently, No.1 Intelligence completed an angel round of financing at a valuation of nearly 100 million yuan, and this round of financing was invested by Hefei Xinzhan District Angel Investment Fund managed by Hefei Innovation Technology Venture Capital Co., Ltd.

3. Longxing Avionics completed tens of millions of A+ round of financing

Longxing Avionics is a domestic avionics manufacturer, focusing on the development of China's large aircraft industry, independently developing a series of domestic airborne avionics equipment such as WQAR, ELT, IP Phone, etc., as well as ground equipment management, scene operation management and other systems in the field of civil aviation digitalization, and is committed to building a comprehensive service provider in the field of airborne avionics equipment and civil aviation digitalization. Recently, Longxing Avionics successfully completed tens of millions of A+ round of financing. This round of financing is continuously increased by the old shareholder Huayu Venture Capital, which fully reflects the high recognition of the company's achievements in the field of avionics by the old shareholders and the great confidence in the company's future development. This round of financing will be mainly used to accelerate the R&D and upgrading of core avionics products, further expand the construction of high-end talent team, and support the company's market expansion

4. Zhencai Holdings received a new round of financing

Zhencai Holdings is a manufacturer and distributor of textile products, the main products are: chiffon, four-way elastic, milk silk, cotton knitting, cotton socks, etc. Recently, Zhencai Holdings received a new round of financing.

5. Mingxun Biotech completed a Pre-A round of financing of over 10 million yuan

Mingxun Biotech is an animal model technology developer, focusing on all kinds of genetic modification model mice fast, personalized customization services, modeling cycle has a monopoly advantage in the world, can be as short as 2 months, to provide homozygous model mice, and can provide customers with professional genetic strategy consulting, is committed to providing cutting-edge, high-end, fast, excellent model biotechnology services and model resources for global universities, research institutes, hospitals, pharmaceutical companies and other life and health-related scientific research teams. Recently, Mingxun Biotech completed the Pre-A round of financing, and the investor is a fund of Guangzhou Financial Holding Group Co., Ltd. Coupled with the investment from investment institutions such as Hunan Entropy One and Shenzhen Zhirong, Mingxun Biotech has raised tens of millions of yuan.

6. Shunfu Precision completed a new round of financing

Shunfu Precision is a R&D and manufacturer of aluminum alloy die-castings, mainly engaged in the R&D, production and sales of aluminum alloy die-casting parts such as electronic control systems for new energy vehicles, auto parts, lamps and lanterns, motors, etc., which can be used in new energy vehicles, 5G communications, mechanical accessories, electrical appliances, lamps and lighting, electronic devices and other fields. Recently, Huayu High-tech Traffic Control Industry Chain Fund, which was initiated by CRRC Capital, completed a new round of investment in Shunfu Precision. This investment will accelerate the cooperation process between Sunny Precision and CRRC Industry in the field of electric drive systems, and provide financial support for the R&D and production of Sunny Precision, so as to help the sustainable development of the company's business.

7. Shenbo Electronics received tens of millions of yuan in Pre-A round of financing

Shenbo Electronics is a new energy vehicle intelligent electronics research and development provider, providing customers with optoelectronic products and R & D services, the main products are body and comfort domain products. It has launched a variety of products such as PEPS smart key, lamp controller, atmosphere light controller, tailgate controller, etc., which are used in Volkswagen, Ford, Cadillac, BMW, General Motors, GAC, Human Horizons and other models. Recently, Shenbo Electronics has received tens of millions of yuan of Pre-A round of investment led by Hegao Capital. This round of financing is mainly used for technology research and development, capacity expansion, and new plant construction; This move will further accelerate the pace of progress in the field of intelligent control.

8. JIYIWEI received a new round of financing

Jiyiwei is a chip semiconductor R&D manufacturer. The company is committed to China's independent and controllable high-end analog/digital mixed-signal IC design and industrialization platform, and provides customers with differentiated and internationally advanced chip solutions through highly competitive technology and innovation capabilities. Recently, Jiyiwei Semiconductor (Shanghai) Co., Ltd. has undergone industrial and commercial changes, and the National Integrated Circuit Industry Investment Fund Phase II Co., Ltd. has been added as shareholders.

9. YconityAI 完成数600

Yconity AI is an AI platform developer that brings an autocomplete experience to everyday business users and automates all tasks. Handle user tasks, identify repetitive work steps, and automatically generate code that automates those tasks. Yconity AI recently announced the completion of a Pre-A round of financing of 6 million yuan, and the investor is Hanshi Investment. In this round of financing, Yconity AI will be used for technology research and development.

10. Obtained strategic investment in food gas biochemistry

Food Gas Biochemical is an industrial waste gas treatment solution provider, the company uses Clostridium gases as the chassis, carbon monoxide, carbon dioxide and other industrial waste gases as raw materials, and industrial waste gases emitted by factories as food, "feeding" genetically edited microorganisms, so that they can produce biofuels, chemical raw materials and other economic products in batches. Recently, Nanjing Food Gas Biochemical Technology Co., Ltd. has undergone industrial and commercial changes, the registered capital has increased to 3.678 million yuan, and the new shareholders Guangxi Tencent Venture Capital Co., Ltd. and Nanjing Micro Enterprise Management Partnership (Limited Partnership) have been added.

11. Moon Biotech completed 300 million yuan C+ round of financing

Moon Biotech is an innovative biotechnology company focusing on the commercialization of microbial resources in China. It is committed to discovering, preserving and identifying new microbial diversity resources with great development value through the world's leading microbial isolation and cultivation technology, aiming to establish the world's largest standardized microbial resource center. Recently, Moon Biotech completed a C+ round of financing of 300 million yuan, which was exclusively invested by SDIC Juli, and Yikai Capital served as the exclusive financial advisor. This round of financing is also the second time that Moon Biotech has received the support of the national team fund after the introduction of the SDIC Venture Fund in the C round of financing. The new round of funds will be mainly used to promote the large-scale production and commercialization of more bio-innovative products of the company, as well as the expansion of its own commercial microbial strain bank and component library, and the further improvement of the biomanufacturing technology platform.

12. Antiy Shengshi completed nearly 100 million yuan in Series A financing

Antiy Saint is a small nucleic acid drug developer, the company is the first company in China to develop antisense oligonucleotide (ASO) drugs targeting RNA splicing and RNA editing, and has a number of the latest international ASO technologies. The company has a number of projects in progress, among which important progress has been made in drug research and development for DMD (Duchenne muscular dystrophy), SCA3 (spinocerebellar ataxia type 3) and other diseases. Recently, Antiy Shengshi completed nearly 100 million yuan in Series A financing. This round of financing was led by SDIC Venture Capital, followed by the old shareholders and Rui Venture Capital SCA3 Industry Fund, to support Antiy Shengshi to promote the research and development of new technologies, the implementation of commercial production, and the strategic layout of international operation. The funds raised in this round will be used to accelerate the advancement of products for Duchenne muscular dystrophy, spinocerebellar ataxia, Huntington's disease and other indications and apply for clinical trial registration, promote the product development of multiple follow-up innovation pipelines, and promote international cooperation.

Foreign investment events

1. LeyLine raises multi-million dollar seed round

LeyLine is an AI-enabled human-machine hybrid intelligence ecosystem developer, committed to launching the world's first AI-enabled human-machine hybrid intelligence ecosystem for games, short dramas, animation, CG and other content production industries. The company offers a professional-grade cloud production pipeline for global collaboration, seamlessly integrating AIGC tools into applications such as UE, Maya, Blender, and Max, and dramatically reducing production costs through an ecosystem that is integrated. LeyLine has recently closed its first multi-million dollar funding round led by Primavera Ventures (VC of Primavera Capital), followed by Boston-based deep tech fund Taihill Ventures and a number of prominent angel investors, including Amir Husain, founder of SparkCognition, and SternHill, founded by Bob Stearns, former CTO of Compaq Computers Partners。

2. Formation Bio获得3.72亿美元D轮融资

Formation Bio (formerly known as TrialSpark) is an American biopharmaceutical manufacturer that is building a next-generation pharmaceutical company focused on bringing new therapies to patients faster and more efficiently. It is committed to developing drugs in-house faster and more efficiently than traditional pharmaceutical companies, as it believes that every day saved during clinical trials will give patients faster access to life-changing treatments. Formation Bio announced the closing of a $372 million Series D funding round led by Andreessen Horowitz with participation from existing shareholders Sanofi, Sequoia Capital, Thrive, Emerson Collective, Lachy Groom, new investors SV Angel Growth and FPV Ventures.

3. Celsius Therapeutics获得8300万美元B轮融资

Celsius Therapeutics是一家专注于基因治疗的医疗服务商，公司正在通过技术突破将单细胞基因组的研究成果转化为针对自身免疫性疾病和癌症的精准疗法，基于Celsius公司的创新方法，研究者可以通过单细胞基因组学了解特定的细胞生态系统，并通过识别引发病变的基因来描绘一种新的靶向药物发现过程，有望为自身免疫疾病和癌症治疗带来重大改变。 近日，Celsius Therapeutics获得8300万美元B轮融资，Catalio Capital Management、Amplitude Venture Capital、Amgen、Third Rock Ventures、Heritage Provider Network、Google Ventures(GV)、Alexandria Venture Investments、Casdin Capital、凯风创投、Fast Track Initiative、Section 32投资。

4. SmartHR received $140 million in Series E financing

SmartHR is a Japanese provider of HR intelligence services that can help companies automate the design of employee benefits and insurance plans, and use government e-government APIs to connect directly with local corporate benefits and insurance offices to speed up the approval process. SmartHR, Japan's leading cloud-based HR software platform, has raised $140 million in Series E funding led by KKR and Teachers's Venture Gowth.

5. Be.EV receives a strategic investment of £55 million

Be.EV is an electric vehicle charging service provider serving more than 1 million electric vehicles, making electric vehicle charging accessible to communities across the UK. Be.EV received £55 million in funding from NatWest and KfW IPEX-Bank.

6. ETW received a strategic investment of $2 million

ETW is a blockchain project developer, mainly engaged in the research and development of artificial intelligence game technology and AI algorithms, in order to improve the intelligence and personalized interaction of games, as well as the depth and complexity of game plots, so as to bring a more profound and immersive game experience to players around the world. ETW announced a $2 million strategic investment from Harvard University.

7. Waypoint Bio raised $14.5 million in seed round

Waypoint Bio is a biomedical technology developer, mainly engaged in the development of novel cell therapies for solid tumors, autoimmune diseases, etc. Waypoint Bio announced the closing of a $14.5 million seed round. The round was led by Hummingbird Ventures, with participation from other institutional investors including Recode Ventures and Fifty Years.

IPO queue

1. Runji New Materials was terminated

Runji New Materials is mainly engaged in the research and development, manufacturing and sales of new high-performance metal structure materials such as alloying element additives, silicon powder materials, grain refiners, etc., to meet the alloying needs of different users, so as to achieve the purpose of energy saving and environmental protection, reducing production costs and improving production efficiency. Today, Runji New Materials was terminated.

2. Termination of Xinyang New Materials

Xinyang New Materials is a manufacturer of FRP and bimetallic composite steel pipes, including glass fiber reinforced epoxy high-pressure FRP oil pipes, pipe fittings, vertical winding large polyester FRP storage tanks, carbon fiber reinforced resin matrix composites, carbon fiber prepregs, etc., mainly used in the field of petroleum production. Today, Xinyang New Materials was terminated.

3. Haisheng tungsten industry was terminated

Haisheng Tungsten Industry Co., Ltd. is an export-oriented enterprise specializing in the production and operation of tungsten and molybdenum series products with independent import and export rights. Today, Haisheng tungsten industry was terminated.

* Non-advertising